Phase II study of weekly paclitaxel carboplatin in the treatment of progressive ovarian cancer.

被引：0
|
作者：
Van der Burg, ME
Vergote, I
Burger, CW
van der Gaast, A
机构：
[1] Univ Rotterdam, Erasmus MC, Med Ctr, Rotterdam, Netherlands
[2] Katholieke Univ Leuven Hosp, Louvain, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5058
引用
收藏
页码：463S / 463S
页数：1
相关论文
共 50 条
  • [1] Phase II study of DMXAA combined with carboplatin and paclitaxel in recurrent ovarian cancer.
    Gabra, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 263S - 263S
  • [2] Weekly paclitaxel treatment of patients with progressive platinum resistant epithelial ovarian cancer.
    Le, T
    Baines, KA
    Rambout, L
    Rezaifer, P
    Al Hayki, M
    Hopkins, L
    Fung, MFK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 488S - 488S
  • [3] Phase II study of neoadjuvant weekly paclitaxel and carboplatin with lapatinib in HER2+breast cancer.
    Wong, Andrea Li Ann
    Tan, Sing Huang
    Soh, I. Peng Thomas
    Tan, Chee Seng
    Lim, Yi Wan
    Pang, Angela
    Ho, Jingshan
    Ow, Samuel Guan Wei
    Sundar, Raghav
    Pang, Mei-Yan
    Chan, Ching-Wan
    Buhari, Shaik Ahmad
    Hartman, Mikael
    Iau, Philip
    Tang, Anthony
    Wong, Nan-Soon
    Yap, Yoon Sim
    Khoo, Bee-Luan
    Thiery, Jean Paul
    Lee, Soo-Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer
    M Harries
    C Moss
    T Perren
    M Gore
    G Hall
    M Everard
    R A'Hern
    I Gibbens
    A Jenkins
    R Shah
    C Cole
    O Pizzada
    S Kaye
    British Journal of Cancer, 2004, 91 : 627 - 632
  • [5] A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer
    Harries, M
    Moss, C
    Perren, T
    Gore, M
    Hall, G
    Everard, M
    A'Hern, R
    Gibbens, I
    Jenkins, A
    Shah, R
    Cole, C
    Pizzada, O
    Kaye, S
    BRITISH JOURNAL OF CANCER, 2004, 91 (04) : 627 - 632
  • [6] Phase I/II study of carboplatin and weekly paclitaxel for advanced non-small cell lung cancer.
    Ohashi, N
    Arita, KI
    Daga, H
    Mito, A
    Nishino, R
    Moritani, C
    Nakamura, K
    Daido, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 687S - 687S
  • [7] A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer.
    Guppy, AE
    Nelstrop, A
    Agarwal, R
    Seckl, MJ
    Rustin, GJS
    BRITISH JOURNAL OF CANCER, 2002, 86 : S44 - S44
  • [8] Phase II study of the combination carboplatin and paclitaxel in patients with ovarian cancer
    Huinink, WWT
    vanWarmerdam, LJC
    Helmerhorst, TJ
    Schaefers, MCW
    Beijnen, JH
    Rodenhuis, S
    ANNALS OF ONCOLOGY, 1997, 8 (04) : 351 - 354
  • [9] A randomized, phase II trial of weekly paclitaxel versus weekly paclitaxel plus carboplatin for first-line metastatic breast cancer.
    Robert, N
    Loesch, D
    Lindquist, D
    Ratnam, S
    Hyman, W
    Whittaker, T
    Logie, K
    Kruger, S
    Pippen, J
    Liu, L
    Goldstein, L
    Asmar, L
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S129 - S129
  • [10] Phase II study of pazopanib with weekly paclitaxel in refractory urothelial cancer.
    Srinivas, Sandy
    Narayanan, Sujata
    Harshman, Lauren Christine
    Pachynski, Russell Kent
    Lam, Anthony P.
    Fan, Alice C.
    Poushnejad, Shermeen
    Haas, Denise
    Vaishampayan, Ulka N.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
12345